FDA grants monopoly over preterm labor prevention drug: 15,000 percent price increase then announced
March 13, 2011 by Jose Luis Flores
Filed under Health
(NaturalNews) Still think the US Food and Drug Administration (FDA) has your best interests in mind? According to new reports, the agency has arbitrarily decided to grant exclusive approval to KV Pharmaceutical to produce the one-and-only FDA-approved premature birth prevention drug — which is really just a modified, patented version of the common hormone progesterone — administered to women with a high risk of preterm delivery. So what used to cost women as little as $10 to buy from their local compounding pharmacy will now cost $1,500, thanks to the FDA. Progesterone injections have long been custom-made by compounding pharmacies and sold for very little to women in need of them because, frankly, they cost very little to produce. But a backroom deal over at the FDA has changed everything, allowing a single pharmaceutical company to gain monopolistic control over the drug, which in turn allows that company to charge whatever it wants …
Visit link:
FDA grants monopoly over preterm labor prevention drug: 15,000 percent price increase then announced
Presented by Global-Information-Network-Society.com
Global Information Network is an exclusive and private club. It is an association or organization. It can be called a “society”. It consists of members from all over the world. Membership is by invitation only. Not all applications will be accepted and not all who apply will qualify.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
